Dengue: Symptoms, Causes, Prevention, and Treatment

Introduction

Every year, millions of people worldwide are affected by dengue, a rapidly spreading mosquito-borne viral disease that has become a major public health concern in tropical and subtropical regions. Increasing urbanization, climate change, population growth, and inadequate mosquito control measures have significantly contributed to the rising global burden of dengue infections.

Dengue is not simply a seasonal fever. In severe cases, it can lead to dangerous complications including internal bleeding, organ impairment, shock syndrome, and even death. Researchers and healthcare professionals are continuously exploring innovative diagnostic techniques, antiviral strategies, vaccine development, and public health interventions to reduce disease transmission and improve patient outcomes.

This article explores dengue symptoms, causes, prevention, treatment strategies, and recent scientific advances in dengue research. It also highlights the growing role of healthcare awareness and global collaboration in controlling this important infectious disease.

Overview of Dengue

Dengue is a mosquito-borne viral infection caused by the dengue virus (DENV). It spreads through the bite of infected Aedes aegypti mosquitoes and is commonly found in tropical and subtropical countries.

The dengue virus belongs to the Flaviviridae family and exists in four different serotypes known as DENV 1, DENV 2, DENV 3, and DENV 4. Infection with one serotype provides lifelong immunity against that particular type but not against the others. As a result, individuals can become infected multiple times during their lifetime.

Nearly half of the world’s population is now considered at risk of dengue infection, making it one of the fastest growing vector-borne diseases globally.

What Causes Dengue?

Dengue is caused by infection with the dengue virus after being bitten by an infected female mosquito, primarily Aedes aegypti. In some regions, Aedes albopictus may also contribute to disease transmission.

Mosquitoes become infected when they feed on the blood of an infected person. After viral replication inside the mosquito, the virus can be transmitted to another human during subsequent bites.

Rare transmission through blood transfusion, organ transplantation, or from mother to child during pregnancy has also been reported in medical literature.

How Dengue Spreads in Communities

Dengue transmission is strongly influenced by environmental and social conditions. Stagnant water accumulation in containers, coolers, flower pots, discarded tires, and urban drainage systems creates ideal mosquito breeding sites.

Rapid urbanization and population density increase human exposure to infected mosquitoes. Climate change and rising temperatures further enhance mosquito survival and viral replication cycles.

Outbreaks commonly occur during rainy seasons when mosquito breeding increases significantly.

Common Symptoms of Dengue

Most individuals infected with dengue experience mild symptoms or may remain asymptomatic. Symptoms usually begin 4 to 10 days after infection and may last for 2 to 7 days.

• High fever up to 40°C (104°F)
• Severe headache
• Pain behind the eyes
• Muscle and joint pain
• Nausea and vomiting
• Swollen lymph glands
• Skin rash

Many patients describe dengue as “breakbone fever” because of the intense muscle and joint pain associated with the infection.

Warning Signs of Severe Dengue

Individuals infected for the second time with a different dengue serotype are at greater risk of severe dengue due to immune enhancement mechanisms.

Symptoms of severe dengue often appear after the fever subsides and require immediate medical attention.

• Severe abdominal pain
• Persistent vomiting
• Rapid breathing
• Bleeding gums or nose
• Fatigue and restlessness
• Blood in vomit or stool
• Pale and cold skin
• Weakness and dehydration

Severe dengue may lead to plasma leakage, hemorrhage, organ failure, and dengue shock syndrome if not managed promptly.

Diagnosis and Laboratory Testing

Accurate and early diagnosis plays a critical role in dengue management. Healthcare professionals use clinical evaluation along with laboratory investigations to confirm infection.

Common diagnostic methods include NS1 antigen testing, RT-PCR analysis, complete blood count evaluation, and antibody detection tests such as IgM and IgG ELISA.

A significant reduction in platelet count and white blood cell count is commonly observed in dengue patients.

Treatment and Clinical Management of Dengue

Currently, there is no specific antiviral drug approved for dengue treatment. Management mainly focuses on supportive care, hydration, fever control, and monitoring complications.

• Adequate rest and hydration
• Oral rehydration solutions
• Paracetamol for fever and pain management
• Avoiding aspirin and ibuprofen due to bleeding risk

Severe dengue cases may require hospitalization, intravenous fluids, blood transfusion, and intensive monitoring.

After recovery, some patients may experience fatigue and weakness for several weeks.

Prevention and Mosquito Control Strategies

Preventing mosquito breeding and avoiding mosquito bites remain the most effective methods for dengue control.

• Use mosquito repellents
• Sleep under mosquito nets
• Wear full body protective clothing
• Remove stagnant water sources
• Install window and door screens
• Community awareness and sanitation programs

Recent Advances in Dengue Research and Treatment

Modern dengue research has advanced rapidly in recent years. Scientists are exploring antiviral compounds, immunotherapy approaches, nanotechnology-based diagnostics, and AI-driven outbreak prediction systems.

Researchers are also studying host immune responses and viral pathogenesis to develop targeted therapeutic interventions.

Advanced molecular diagnostics are improving early disease detection and surveillance efficiency in endemic regions.

Dengue Vaccines and Future Innovations

Recent years have seen significant progress in dengue vaccine development. The World Health Organization now recommends Qdenga (TAK-003), a tetravalent vaccine designed to protect against all four dengue virus serotypes.

Clinical studies suggest approximately 80 percent effectiveness and long-term protective benefits in many individuals.

Other promising vaccine candidates currently under investigation include:

• Butantan-DV developed in Brazil
• TV003 and TV005 vaccine candidates

Future innovations may include personalized vaccine approaches, genetically modified mosquito control systems, and advanced global surveillance technologies.

Global Impact of Dengue

Dengue is now endemic in more than 100 countries and continues to expand geographically. Increasing international travel, climate variation, and urban growth contribute to wider disease spread.

The economic burden associated with hospitalization, vector control programs, productivity loss, and healthcare expenditure remains substantial in many developing countries.

Conclusion

Dengue is a serious but preventable viral disease that continues to challenge healthcare systems worldwide. Early diagnosis, supportive clinical management, mosquito control strategies, and public awareness are essential for reducing disease burden and mortality.

Ongoing research in vaccine development, antiviral therapy, molecular diagnostics, and vector control technologies offers hope for better disease prevention and future outbreak management.

Researchers, healthcare professionals, and academicians must continue contributing to scientific innovation, interdisciplinary collaboration, and public health education to combat dengue effectively.

Why Publish with BJMHR?

The British Journal of Medical and Health Research (BJMHR) provides a trusted international platform for publishing innovative research in infectious diseases, public health, pharmacy practice, and biomedical sciences.

Publishing with BJMHR helps researchers gain global visibility, academic recognition, and opportunities for scientific collaboration.

Benefits of publishing with BJMHR include:

• Peer reviewed publication process
• Open access global readership
• Strong academic visibility
• Rapid editorial communication
• International healthcare research exposure

Researchers are encouraged to submit original manuscripts, review articles, clinical studies, and public health research through BJMHR to support evidence based medical advancement and global healthcare improvement.